Smart Innovation
Antimicrobial resistance (AMR)
AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights
For Researchers and Entrepreneurs who wish to investigate, develop and commercialize novel vaccines, diagnostics and antimicrobials to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.
AMR Insights is for:
- Researchers at Universities and University Medical Centers
- Researchers at Research Institutes
- R&D professionals in Pharma, Biopharma and Diagnostics companies
- Entrepreneurs in start-up’s and spin off companies
- Innovators, Venture Capitalists.
Latest Topics
-
25 April 2025The Global Challenge of Antimicrobial Resistance: Patent filing analysis a decade on
Key Findings: Patent Filing Trends: Approximately 12,500 antimicrobial-related patent families were filed globally since 2015, indicating a steady increase. However, this growth is modest compared to fields like oncology, highlighting the need for greater investment in antimicrobial research.marks-clerk.com Geographical Distribution: China leads in both the number of filings and top applicants, with institutions like the […]
Read more... -
23 April 2025Nanobiosensors for Antimicrobial Resistance Surveillance: Possibilities and Challenges
Antimicrobial resistance (AMR) is a pressing global health concern, causing the spread of antibiotic-resistant bacteria and genes. Traditional methods, such as culture-based techniques and molecular assays, are costly and time-consuming. Nanobiosensors, a hybrid instrument combining nanomaterials with biological recognition elements, offer a scalable, precise detection method. This chapter explores the molecular basis of resistance mechanisms, […]
Read more... -
18 April 2025Barriers to the widespread adoption of diagnostic artificial intelligence for preventing antimicrobial resistance
Antimicrobial resistance (AMR) is a major public health challenge due to overuse of antimicrobial agents. A study found that ethical dilemmas may hinder the adoption of diagnostic AI. A survey across eight countries showed societal preference for both AI types, with gender and age differences and opposition to AI standardization. This highlights the need for […]
Read more...
More news related to Smart innovation
